RecruitingNot ApplicableNCT06926608

Actívatexto: Advancing Smoking Cessation and Physical Activity Among Latinos


Sponsor

University of Rochester

Enrollment

408 participants

Start Date

Jun 17, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this randomized controlled trial is to assess the efficacy of Actívatexto (Aim 1) and the mediators of the presumed treatment effect (Aim 2) among Latino adults who smoke. Actívatexto is a mobile intervention that integrates four components: 1) a text messaging program that promotes both smoking cessation and physical activity, 2) wearable devices to monitor physical activity, 3) smoking cessation pharmacotherapy \[i.e., nicotine replacement therapies (NRT)\], and 4) an online dashboard where the research team manages participants' incoming and outgoing data from both the text messaging program and wearable devices.


Eligibility

Min Age: 18 Years

Inclusion Criteria10

  • Self-identify as Hispanic and/or Latino
  • Know how to read and speak English and/or Spanish
  • Be ≥ 18 years of age
  • Not meet the recommended levels of physical activity (150 minutes of moderate to vigorous physical activity)
  • Smoke cigarettes at least 3 days per week
  • Be interested in quitting smoking in the next 30 days
  • Have a cellphone with text messaging capability
  • Know how to utilize text messages
  • Be willing to wear a wearable device daily to monitor physical activity
  • Be willing to complete all study visits

Exclusion Criteria5

  • Use of tobacco products other than cigarettes in the past 30 days (including e-cigarettes)
  • Being pregnant or breastfeeding
  • Plan to move from their current residence in the next six months
  • Another household member enrolled in the study
  • Unable to become more physically active or engage in a fitness appraisal

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALActívatexto

Actívatexto is a mobile intervention that promotes both smoking cessation and physical activity. Actívatexto integrates four components: 1) a text messaging program that promotes both smoking cessation and physical activity, 2) wearable devices to monitor physical activity, 3) smoking cessation pharmacotherapy (i.e., nicotine replacement therapies), and 4) an online dashboard where the research team manages participants' incoming and outgoing data from both the text messaging program and wearable devices.

BEHAVIORALDecídetexto

Decídetexto is a mobile intervention that solely promotes smoking cessation. Decídetexto integrates three components: 1) a text messaging program that solely promotes smoking cessation, 2) smoking cessation pharmacotherapy (i.e., nicotine replacement therapies), and 3) an online dashboard where the research team manages participants' incoming and outgoing data from the text messaging program.


Locations(1)

University of Rochester Medical Center

Rochester, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06926608


Related Trials